IndiaOne Finance - Company Dashboard

Governance Classic Home

Sanofi Consumer Healthcare India LtdPharmaceuticalsINE0UOS01011Standalone₹4015.85+12.90 (+0.32%)Jun-26

Valuation

Market Cap₹9.29K Cr

TTM PE34.92x

Forward PE34.31x

PEG11.16

Book Value₹111.59

P/B36.14x

TTM EPS₹115.49

Fwd EPS₹117.57

TTM Revenue₹949.80 Cr

TTM PAT₹266.00 Cr

TTM EBITDA₹352.90 Cr

TTM EBIT₹339.70 Cr

Last Qtr PAT₹68.80 Cr

Last Qtr EBITDA₹89.30 Cr

Last Qtr EBIT₹86.00 Cr

Profitability

ROE103.50%

ROCE140.00%

TTM NPM28.01%

TTM EBITDA %37.16%

Curr OPM28.43%

Last OPM28.88%

Curr NPM—

Last NPM—

Curr EPS₹29.87

Last EPS₹29.44

Balance sheet

Equity₹23.00 Cr

Reserve₹234.00 Cr

Total Debt₹0.00 Cr

D/E0.00x

Interest %0.58%

Curr Interest₹0.40 Cr

Price / range

Close₹4033.40

vs 52W High-24.68%

vs 52W Low+2.74%

MA50—

MA200—

Returns

1D+1.10%

1W-0.57%

1M-7.44%

3M-18.84%

6M-6.22%

1Y-23.66%

2Y-21.66%

3Y—

5Y—

Diwali-11.16%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	148.17	3.58%
DIVISLAB	9375.00	₹2.49L Cr	84.62	17.55%
TORNTPHARM	4840.00	₹1.84L Cr	78.80	25.43%
ZYDUSLIFE	1160.00	₹1.16L Cr	33.21	12.96%
CIPLA	1394.50	₹1.13L Cr	36.64	8.93%
LAURUSLABS	1954.00	₹1.06L Cr	120.92	16.46%
AUROPHARMA	1734.00	₹99.77K Cr	38.79	6.84%
DRREDDY	1185.00	₹98.91K Cr	148.68	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25
Revenue	235.70+6.7%	229.20	251	233.90	220.90
Other Income	6.30	5.60	4.60	3	5.60
Total Income	242+6.8%	234.80	255.60	236.90	226.50
Interest	0.40	0.50	0.50	0.60	0.50
Expenditure	-150.10+2.7%	-144.10	-165.10	-152.80	-154.20
PBDT	0	0	0	0	0
EBITDA	89.30+27.2%	88.80	89.80	85	70.20
Depreciation	-3.30	-3.20	-3.40	-3.30	-3
EBIT	86+28.0%	85.60	86.40	81.70	67.20
PBT	91.90+16.5%	90.70	90.50	84.10	78.90
Tax	-23.10	-22.90	-24	-21.20	-18.20
Equity	23	23	0	0	23
OPM	37.98	38.63	36.06	35.96	34.83
Net Profit	68.80+13.3%	67.80	66.50	62.90	60.70
NPM	28.43	28.88	26.49	26.89	26.80
EPS	29.87+13.3%	29.44	28.87	27.31	26.36

Yearly results

Last 6 financial years · YoY % vs previous FY

No yearly result data.

No financial result data.

Yearly results

Last 6 financial years · YoY % vs previous FY

No yearly result data.

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	75	19 Jun 2026
2025	Final Dividend	55	28 Apr 2025
2025	Final Dividend	55	17 Apr 2025

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split